Emblaveo is a fixed-dose IV treatment that combines aztreonam, a monobactam antibiotic, and avibactam, a β-lactamase inhibitor.
The most common adverse reactions reported with aztreonam-avibactam + metronidazole were hepatic ... in a single-dose vial as a lyophilized powder containing 1.5g of aztreonam and 0.5g of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback